Friday, December 21, 2012

Potential combo of Belinostat and Folotyn


Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article

http://news.yahoo.com/spectrum-pharmas-blood-cancer-drug-meets-trial-goal-164551587--finance.html

QUOTE
MLV & Co analyst George Zavoico said Folotyn and belinostat have different mechanisms of action, and having two drugs for the same indication could be useful in cases of relapsed patients who develop resistance to one of them.
QUOTE

No comments:

Post a Comment